BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20204281)

  • 1. The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.
    Cheng Y; Li J; Martinka M; Li G
    Oncol Rep; 2010 Apr; 23(4):973-9. PubMed ID: 20204281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
    Garate M; Wani AA; Li G
    Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
    Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
    Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
    Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
    Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
    Gao K; Dai DL; Martinka M; Li G
    Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear ING2 expression is reduced in human cutaneous melanomas.
    Lu F; Dai DL; Martinka M; Ho V; Li G
    Br J Cancer; 2006 Jul; 95(1):80-6. PubMed ID: 16755297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
    Siegel D; Franklin WA; Ross D
    Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    PLoS One; 2011 Feb; 6(2):e17578. PubMed ID: 21386910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of NAD(P)H:quinone oxidoreductase-1 on pigmentation.
    Choi TY; Sohn KC; Kim JH; Kim SM; Kim CH; Hwang JS; Lee JH; Kim CD; Yoon TJ
    J Invest Dermatol; 2010 Mar; 130(3):784-92. PubMed ID: 19759547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.
    Tong YH; Zhang B; Yan YY; Fan Y; Yu JW; Kong SS; Zhang D; Fang L; Su D; Lin NM
    Oncotarget; 2017 Jul; 8(28):45750-45758. PubMed ID: 28501854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis.
    Wilson MW; Schelonka LP; Siegel D; Meininger A; Ross D
    Curr Eye Res; 2001 May; 22(5):348-52. PubMed ID: 11600935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.